Hancock Whitney Corp Natera, Inc. Transaction History

Hancock Whitney Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$30.32 - $91.33 $95,356 - $287,232	-3,145 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$86.26 - $119.0 $38,385 - $52,955	445 Added 16.48%	3,145 $294,000
Q3 2021 Nov 04, 2021	SELL	$100.17 - $126.36 $14,324 - $18,069	-143 Reduced 5.03%	2,700 $301,000
Q2 2021 Aug 09, 2021	SELL	$86.05 - $119.72 $6,367 - $8,859	-74 Reduced 2.54%	2,843 $323,000
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $102,903 - $139,905	-1,125 Reduced 27.83%	2,917 $296,000
Q4 2020 Feb 09, 2021	SELL	$66.66 - $111.74 $66,393 - $111,293	-996 Reduced 19.77%	4,042 $402,000
Q3 2020 Nov 05, 2020	SELL	$45.89 - $72.67 $25,193 - $39,895	-549 Reduced 9.83%	5,038 $364,000
Q2 2020 Jul 30, 2020	SELL	$26.36 - $49.86 $115,535 - $218,536	-4,383 Reduced 43.96%	5,587 $279,000
Q1 2020 May 08, 2020	BUY	$17.27 - $40.17 $172,181 - $400,494	9,970 New	9,970 $298,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Hancock Whitney Corp, based on Form 13F filings with the SEC.

Stay updated on Hancock Whitney Corp with notifications on news.